Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study.

Details

Serval ID
serval:BIB_C46948434A9D
Type
Article: article from journal or magazin.
Collection
Publications
Title
Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study.
Journal
BMJ open
Author(s)
Kiener L.M., Schwendener C.L., Jafflin K., Meier A., Reber N., Schärli Maurer S., Muggli F., Gültekin N., Huber B.M., Merten S., Deml M.J., Tarr P.E.
ISSN
2044-6055 (Electronic)
ISSN-L
2044-6055
Publication state
Published
Issued date
21/04/2022
Peer-reviewed
Oui
Volume
12
Number
4
Pages
e053754
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: epublish
Abstract
Identifying factors associated with human papillomavirus (HPV) vaccine uptake is essential for designing successful vaccination programmes. We aimed to examine the association between vaccine hesitancy (VH) and HPV vaccine uptake among male and female youth in Switzerland.
With a cross-sectional study, an interview-based questionnaire was used to collect information on sociodemographic factors, vaccination records and to measure the prevalence of VH using the Youth Attitudes about Vaccines scale (YAV-5), a modified version of the Parent Attitudes about Childhood Vaccinations survey instrument.
Eligible male and female participants, 15-26 years of age, were recruited through physicians' offices and military enlistment in all three language regions of Switzerland. Of 1001 participants, we included 674 participants with a vaccination record available (415 males and 259 females) in this study.
The outcome was uptake for HPV vaccine (having received ≥1 dose of HPV vaccine). Covariates were VH, sex, age and other sociodemographics.
151 (58%) female and 64 (15%) male participants received ≥1 dose of HPV vaccine. 81 (31%) female and 92 (22%) male participants were VH (YAV-5-Score >50). The odds for being unvaccinated were higher for VH women than non-VH women, adjusted OR=4.90 (95% CI 2.53 to 9.50), but similar among VH and non-VH men, OR=1.90 (95% CI 0.84 to 4.31). The odds for being unvaccinated were lower for younger men (born on or after 1 July 2002) than older men (born before 1 July 2002), OR=0.34 (95% CI 0.14 to 0.81), but we found no association between age and vaccine uptake for female youth, OR=0.97 (95% CI 0.48 to 1.97).
VH was associated with lower HPV vaccine uptake in female youth but not male youth in our study population in Switzerland. Our findings suggest that issues other than VH contribute to HPV underimmunisation in male youth in Switzerland.
Keywords
Adolescent, Aged, Cross-Sectional Studies, Female, Humans, Male, Papillomavirus Infections/epidemiology, Papillomavirus Infections/prevention & control, Papillomavirus Vaccines, Switzerland, Vaccination, Vaccination Hesitancy, complementary medicine, preventive medicine, public health, sexual medicine, virology
Pubmed
Web of science
Open Access
Yes
Create date
10/10/2023 10:02
Last modification date
13/04/2024 7:06
Usage data